Ten Capital Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$768K Buy
1,639
+360
+28% +$151K 0.22% 41
2023
Q1
$439K Buy
1,279
+934
+271% +$315K 0.14% 49
2022
Q4
$126K Sell
345
-17
-5% -$6.03K 0.05% 118
2022
Q3
$117K Sell
362
-27
-7% -$8.55K 0.05% 112
2022
Q2
$126K Hold
389
0.05% 107
2022
Q1
$111K Hold
389
0.05% 109
2021
Q4
$107K Buy
389
+45
+13% +$11.4K 0.04% 91
2021
Q3
$79K Buy
344
+300
+682% +$74K 0.04% 106
2021
Q2
$10K Buy
+44
New +$8.84K ﹤0.01% 314

Other funds holding LLY

Ten Capital Wealth Advisors's LLY Position: Q2 2023 in Review

Ten Capital Wealth Advisors increased its Eli Lilly (LLY) stake by 28% in Q2 2023, buying an estimated $151K and bringing the position to 1,639 shares worth $768K. The position accounts for 0.22% of the portfolio, ranked #41.

Ten Capital Wealth Advisors first reported a position in LLY in Q2 2021 and has held it in 9 quarters since. 2,814 funds tracked by Wall St. Rank hold LLY as of Q2 2023.

  • Ten Capital Wealth Advisors held 1,639 shares of Eli Lilly worth $768K as of Q2 2023.
  • Ten Capital Wealth Advisors bought 360 Eli Lilly shares in Q2 2023, an estimated $151K.
  • Eli Lilly made up 0.22% of Ten Capital Wealth Advisors's portfolio in Q2 2023, its #41 holding.
  • Ten Capital Wealth Advisors first reported a position in Eli Lilly in Q2 2021 and has held it in 9 quarters since.
  • 2,814 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2023.

Based on Ten Capital Wealth Advisors's 13F filing for Q2 2023, filed 31 Jul 2023.